Long-term follow-up and exploratory analysis of lenvatinib in patients with metastatic or recurrent thymic carcinoma: Results from the multicenter, phase 2 REMORA trial
Seiji Niho, Jun Sato, Miyako Satouchi, Shoichi Itoh, Yusuke Okuma, Hidenori Mizugaki, Haruyasu Murakami, Yasuhito Fujisaka, Toshiyuki Kozuki, Kenichi Nakamura, Ryunosuke Machida, Yuichiro Ohe, Toshiyuki Tamai, Hiroki Ikezawa, Noboru Yamamoto
Topics & Concepts
LenvatinibMedicineHazard ratioInternal medicineAdverse effectConfidence intervalOncologyClinical trialGastroenterologyCancerThyroid cancerMyasthenia Gravis and ThymomaGastrointestinal Tumor Research and TreatmentLymphatic Disorders and Treatments